BIO from the BAYOU: Build Your Biotech Network with Key Opinion Leaders and Investors

Are you struggling to find investors, funding, collaborators, and strategic connections in the ever-changing world of biotech? This show empowers bio…
Jun 5th, 2024 | 30:56

Episode 38: Unveiling T-Vant - Tulane's Revolutionary Vaccine Adjuvant with Key Opinion Leaders Lisa Morici and James McLachlan (RE-RELEASE)

Delve into the groundbreaking world of novel vaccine adjuvants with guests Lisa Morici, PhD, Professor of Microbiology, and James McLachlan, PhD, Associate Professor of Immunology, who’s labs collaborate at the Tulane University School of Medicine. This episode spotlights their innovative vaccine adjuvant, T-Vant, detailing its conception, evolution, and why it holds a transformative edge over existing adjuvants. (And yes, vaccine companies – it IS available to license and partner!) Discussion extends to the current vaccine landscape, exploring shifts, trends, and the critical role of advanced adjuvants like T-Vant. Guiding us through this informative journey is our frequent (and popular) host, Elaine Hamm, PhD.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.